Calendar NovoCure Limited

Equities

NVCR

JE00BYSS4X48

Market Closed - Nasdaq 04:00:00 2024-03-01 pm EST 5-day change 1st Jan Change
16.25 USD +6.14% Intraday chart for NovoCure Limited +6.77% +8.84%

Chart calendar NovoCure Limited

56cd6e37f0901ef5b27cf7afcbbd.G2KyUygWcV-J4MU-3nM35JYBtQ2R_BT2de15ZLmYK84.eQWCYGZyIjzc2KphhzEGsfdC027fiyTOLY8PBdvpTqU2UMg8SlwTPPDRsg~974db7981f05a63b2e72f99be89f2b53

Upcoming events on NovoCure Limited

2024-05-01 Q1 2024 Earnings Release (Projected)
2024-07-24 Q2 2024 Earnings Release (Projected)
2024-10-23 Q3 2024 Earnings Release (Projected)
2025-02-19 Q4 2024 Earnings Release (Projected)

Past events on NovoCure Limited

2024-02-22 08:00 am Q4 2023 Earnings Call
2024-02-22 07:00 am Q4 2023 Earnings Release
2024-01-10 10:30 am JPMorgan Healthcare Conference
2023-11-29 03:30 pm Piper Sandler Healthcare Conference - Fireside Chat
2023-11-18 11:35 am Society for Neuro Oncology Meeting
2023-11-17 11:06 pm Society for Neuro Oncology Meeting
2023-11-17 10:30 pm Society for Neuro Oncology Meeting - Prolonged
2023-11-17 10:30 pm Society for Neuro Oncology Meeting
2023-11-17 10:30 pm Society for Neuro Oncology Meeting - Molecular characterization
2023-11-17 10:30 pm Society for Neuro Oncology Meeting - Development of Tumor
2023-11-17 10:30 pm Society for Neuro Oncology Meeting - Tumor Treating Fields
2023-11-17 10:30 pm Society for Neuro Oncology Meeting - Adopting Tumor
2023-11-17 10:30 pm Society for Neuro Oncology Meeting - The pivotal TRIDENT
2023-11-17 10:30 pm Society for Neuro Oncology Meeting - The pivotal METIS
2023-11-17 10:30 pm Society for Neuro Oncology Meeting - Investigating safety
2023-11-17 10:30 pm Society for Neuro Oncology Meeting - Advanced MRI
2023-11-17 10:30 pm Society for Neuro Oncology Meeting - Distant progression
2023-11-17 10:30 pm Society for Neuro Oncology Meeting - Real world experience
2023-11-17 10:30 pm Society for Neuro Oncology Meeting - Long-term global
2023-11-17 10:30 pm Society for Neuro Oncology Meeting - Tumor Treating Fields: Real-World

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
351
351
0.05%
494
494
0.14%
535
539
-0.81%
538
537
0.15%
509
509
-0.01%

539

EBITDA
Million USD
Released
Forecast
Spread
7,55
9,20
-17.93%
39,6
40,3
-1.87%
-34,1
-20,6
-65.7%
-78,9
-43,7
-80.45%
-222
-233
4.77%

-218

EBIT
Million USD
Released
Forecast
Spread
-0,91
6,79
-113.45%
30,4
34,9
-12.99%
-44,3
-28,8
-53.83%
-89,5
-77,0
-16.3%
-233
-246
5.21%

-216

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-8,82
-2,12
-316.03%
18,1
25,8
-29.93%
-52,1
-36,7
-41.76%
-81,8
-79,7
-2.67%
-192
-208
7.72%

-166

Net income
Million USD
Released
Forecast
Spread
-7,23
-10,5
31.43%
19,8
28,8
-31.23%
-58,4
-41,1
-41.81%
-92,5
-88,0
-5.13%
-207
-217
4.38%

-180

EPS
USD
Released
Forecast
Spread
-0,07
-0,10
31.95%
0,20
0,26
-23.66%
-0,56
-0,41
-37.32%
-0,88
-0,82
-6.68%
-1,95
-2,02
3.64%

-1,73

Announcement Date27/02/2025/02/2124/02/2223/02/2322/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
133
134
-0.95%
138
134
2.42%
141
135
4.25%
131
133
-1.79%
128
127
0.75%
122
128
-4.49%
126
124
1.45%
127
129
-1.12%
134
134
-0.01%

132


134


137


139


140

EBITDA
Million USD
Released
Forecast
Spread
-20,7
-4,23
-389.63%
1,80
-20,3
108.87%
-18,5
-11,6
-59.56%
-22,0
-23,8
7.88%
-40,3
-24,4
-64.79%
-57,5
-36,2
-58.72%
-59,9
-54,6
-9.7%
-55,4
-60,5
8.34%
-49,0
-59,1
17.12%

-59,0


-58,4


-56,3


-49,1


-59,9

EBIT
Million USD
Released
Forecast
Spread
-23,4
-7,85
-198.13%
-0,81
-18,4
95.63%
-21,1
-12,9
-63.63%
-24,6
-25,8
4.65%
-43,0
-29,1
-47.83%
-60,2
-35,5
-69.72%
-62,7
-60,2
-4.15%
-58,2
-65,5
11.12%
-51,7
-64,6
19.94%

-54,1


-54,6


-54,6


-52,5


-62,8

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-25,6
-10,2
-151.37%
-2,52
-22,1
88.63%
-23,4
-15,7
-48.36%
-23,4
-28,9
18.94%
-32,6
-30,5
-6.76%
-51,1
-35,5
-43.89%
-53,9
-51,0
-5.71%
-48,2
-56,8
15.1%
-38,5
-54,7
29.49%

-41,3


-42,3


-42,9


-41,2


-54,1

Net income
Million USD
Released
Forecast
Spread
-26,5
-11,1
-138.47%
-4,65
-19,9
76.69%
-24,0
-15,6
-53.44%
-26,6
-28,9
7.94%
-37,3
-32,8
-13.79%
-53,1
-37,9
-40.18%
-57,4
-52,2
-9.94%
-49,5
-56,0
11.65%
-47,1
-56,6
16.75%

-45,7


-46,0


-46,0


-44,3


-54,1

EPS
USD
Released
Forecast
Spread
-0,25
-0,11
-133.95%
-0,04
-0,19
79.32%
-0,23
-0,14
-59.3%
-0,25
-0,28
9.18%
-0,36
-0,31
-15.31%
-0,50
-0,34
-47.06%
-0,54
-0,50
-8%
-0,46
-0,53
12.38%
-0,45
-0,52
13.7%

-0,43


-0,44


-0,42


-0,44


-0,44

Announcement Date24/02/2228/04/2228/07/2227/10/2223/02/2304/05/2327/07/2326/10/2322/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW